ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Merck KGaA, Darmstadt, Germany clinical trials

Part of E. Merck KG, which holds 70.274% as of 2025-12-31. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 523 studies whose lead sponsor is Merck KGaA, Darmstadt, Germany or one of 4 companies grouped under it. 17 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 18, 2026.

Our grouping of 5 registry names, not the registry’s. See them and correct one ↓

Compare Merck KGaA, Darmstadt, Germany with Johnson & Johnson and Genmab →

Pipeline: 14 programs

Each counted once: 14 with a study Merck KGaA, Darmstadt, Germany leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 3 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Merck KGaA, Darmstadt, Germany’s own registered studies; Merck KGaA, Darmstadt, Germany’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Merck KGaA, Darmstadt, Germany’s studies test, most open studies first — 95 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 95; every drug is on its own page, and each page lists its sponsors.

Coming up

7 of Merck KGaA, Darmstadt, Germany’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 2N’26
  2. D
  3. 1J’27
  4. 1F
  5. M
  6. 1A
  7. 1M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add all 7 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 20, 2026.

All 523 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now173%Recruiting 15 · Not yet recruiting 2
  • Under way, not recruiting102%
  • Completed39275%
  • Stopped early10119%Terminated 90 · Withdrawn 10 · Suspended 1
  • Status unknown or other31%Available 2 · Approved for marketing 1

Phase

Where

Over the years

  1. 07
  2. 4908
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 1026

By the year each study started; 95 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Merck KGaA, Darmstadt, Germany.

  • Merck KGaA, Darmstadt, Germany
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    275 studies
  • EMD Serono
    Acquired — became part of Merck KGaA, Darmstadt, Germany, Jan 5, 2007 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    91 studies →
  • EMD Serono Research & Development Institute, Inc.
    Acquired — became part of Merck KGaA, Darmstadt, Germany, Jan 5, 2007 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    87 studies →
  • Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    56 studies →
  • SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
    Acquired — became part of Merck KGaA, Darmstadt, Germany, Jul 1, 2025 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    14 studies →

Focus areas

Conditions Merck KGaA, Darmstadt, Germany leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 523. Browse all 523 →